MondegarAI
SB INVESTMENT ADVISERS (UK) LTD

Q1 2026 · 13F-HR

SB INVESTMENT ADVISERS (UK) LTDholdings as filed

Filed 2026-05-18 · accession 0001493152-26-023965

$7.73B
Reported value
10
Positions
2026-03-31
Period end
View analyzed profile →PRO

The Brief · SB INVESTMENT ADVISERS (UK) LTD · Q1 2026

AI · grounded in 13F

SB INVESTMENT ADVISERS (UK) LTD reduced its position in ROIVANT SCIENCES LTD by 83.72%. The fund also trimmed its holdings in VIR by 16.53% and NRGV by 16.19%. Additionally, the fund decreased its stake in COMP by 12.20%. Total AUM for the period stood at $7.73B across 10 positions.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
22266T109CPNGCOUPANG INC$5.47B70.7%289,542,259CommonSOLE
G4124C109GRABGRAB HOLDINGS LIMITED$1.47B19.0%401,796,672CommonSOLE
75943R102RLAYRELAY THERAPEUTICS INC$277.7M3.59%27,904,963CommonSOLE
20464U100COMPCOMPASS INC$160.9M2.08%22,004,702CommonSOLE
92764N102VIRVIR BIOTECHNOLOGY INC$98.1M1.27%10,948,093CommonSOLE
051774107AURAURORA INNOVATION INC$81.6M1.06%19,811,760CommonSOLE
G76279101ROIVROIVANT SCIENCES LTD$74.0M0.96%2,671,732CommonSOLE
29280W109NRGVENERGY VAULT HOLDINGS INC$51.3M0.66%15,535,631CommonSOLE
35969L108YMMFULL TRUCK ALLIANCE CO LTD$43.8M0.57%5,272,390CommonSOLE
37611X209DNAGINKGO BIOWORKS HOLDINGS INC$3.7M0.05%610,729CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.